BMO Capital Markets

Lithium Ionic Announces Binding Term Sheet for US$20 Million Royalty Financing with Appian

Retrieved on: 
星期四, 五月 30, 2024
Lithium, Bandeira, Documentation, Mining, BMO Capital Markets, IRR, Royalty, LTH, Feasibility study, Music

TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”), is pleased to announce that it has executed a binding term sheet (the “Term Sheet”) with Appian Capital Advisory LLP (“Appian”) to sell a 2.25% gross revenue royalty on its Bandeira Deposit in exchange for an upfront cash consideration of US$20,000,000 (the “Royalty”).

Key Points: 
  • TORONTO, May 30, 2024 (GLOBE NEWSWIRE) -- Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the “Company”), is pleased to announce that it has executed a binding term sheet (the “Term Sheet”) with Appian Capital Advisory LLP (“Appian”) to sell a 2.25% gross revenue royalty on its Bandeira Deposit in exchange for an upfront cash consideration of US$20,000,000 (the “Royalty”).
  • Appian is an investment advisor to long-term, value-focused private capital funds that invest solely in mining and mining-related companies.
  • Lithium Ionic intends to use the proceeds of the Royalty to further advance the development and construction of its world-class Bandeira Lithium Project (“Bandeira” or the “Project”), located within the Lithium Valley in Minas Gerais State, Brazil.
  • The Lithium Valley is a unique geological belt that hosts a significant concentration of lithium-bearing pegmatites and has emerged as a globally significant lithium production center.

Merus Announces Pricing of Upsized Public Offering of Common Shares

Retrieved on: 
星期四, 五月 30, 2024
Investment, Jefferies, EEA, BMO Capital Markets, Form, Attention, Madison Avenue, BofA Securities, European Economic Area, Telephone, Sale, Communication, Security (finance), Finance, Advertising, Jefferies Group, S-3, SVB Securities, State Street, FSMA, Person, Floor, Prospectus, Guggenheim Partners, File

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the pricing of an upsized underwritten public offering of 7,550,000 common shares, at a public offering price of $53.00 per share (the “Offer Shares”).

Key Points: 
  • UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the pricing of an upsized underwritten public offering of 7,550,000 common shares, at a public offering price of $53.00 per share (the “Offer Shares”).
  • Merus also granted the underwriters a 30-day option to purchase up to an additional 1,132,500 common shares (the “Option Shares” and together with the Offer Shares, the “Shares”).
  • All of the shares in the offering are to be sold by Merus.
  • Jefferies, BofA Securities, Leerink Partners, Guggenheim Securities and BMO Capital Markets are acting as joint book-running managers for the offering.

Merus N.V. Announces Proposed Public Offering of Common Shares

Retrieved on: 
星期二, 五月 28, 2024
Investment, Jefferies, EEA, BMO Capital Markets, Form, Attention, Madison Avenue, BofA Securities, European Economic Area, Telephone, Sale, Communication, Security (finance), Finance, Advertising, Jefferies Group, S-3, SVB Securities, State Street, FSMA, Person, Floor, Prospectus, Guggenheim Partners, File

UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of $300,000,000 of its common shares (the “Offer Shares”).

Key Points: 
  • UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of $300,000,000 of its common shares (the “Offer Shares”).
  • All of the common shares are being offered by Merus.
  • In addition, Merus expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the Offer Shares (the “Option Shares” and together with the Offer Shares, the “Shares”).
  • Jefferies, BofA Securities, Leerink Partners, Guggenheim Securities and BMO Capital Markets are acting as joint book-running managers for the offering.

Gold Royalty Announces US$30 Million Bought Deal Financing

Retrieved on: 
星期二, 五月 28, 2024
Offering, National bank, Metal, Acquisition, Unit, Date, News, Indian stock exchange, Exercise, Stream, Sale, BMO Capital Markets, Adriatic Sea, Form, Prospectus, PSA, T+3, System, Warrant, T+1, Orion, Security (finance)

VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Gold Royalty Corp. (“Gold Royalty” or the “Company”) (NYSE American: GROY) is pleased to announce that it has entered into an agreement with National Bank Financial Inc. and BMO Capital Markets Corp., as joint book-runners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 17,442,000 units of the Company (the “Units”) at a price of US$1.72 per Unit (the “Offering Price”), for aggregate gross proceeds of approximately US$30 million (the “Offering”).

Key Points: 
  • Each Unit will consist of one common share of the Company (each a “Common Share”) and one common share purchase warrant (each a “Warrant”).
  • The Company has agreed to use commercially reasonable efforts to list the Warrants on the NYSE American following closing of the Offering.
  • Under the terms of the PSA, Gold Royalty will pay US$50 million to acquire the Stream from Orion at the closing of the Acquisition, comprised of US$45 million payable in cash and US$5 million to be satisfied by the issuance of 2,906,977 Gold Royalty shares.
  • As a result, the Warrants will not be immediately tradeable over the facilities of the NYSE American on the Closing Date.

Fidelis Insurance Group Announces Closing of Secondary Offering of its Common Shares

Retrieved on: 
星期二, 五月 28, 2024
Professional Services, Insurance, Finance, Offering, Barclays, J. P. Morgan, Goldman Sachs, ISI, Telephone, Sale, BMO Capital Markets, Citigroup, Prospectus, Attention, UBS, Keefe, Bruyette & Woods, Broadridge Financial Solutions, Security (finance)

Fidelis Insurance Holdings Limited (NYSE: FIHL) (“Fidelis Insurance Group” or “FIHL”), a global specialty insurer, today announced the closing of its underwritten secondary public offering (the “Offering”) of 9,000,000 common shares by certain of its shareholders (the “Selling Shareholders”) at a price to the public of $16.00 per common share.

Key Points: 
  • Fidelis Insurance Holdings Limited (NYSE: FIHL) (“Fidelis Insurance Group” or “FIHL”), a global specialty insurer, today announced the closing of its underwritten secondary public offering (the “Offering”) of 9,000,000 common shares by certain of its shareholders (the “Selling Shareholders”) at a price to the public of $16.00 per common share.
  • The underwriters exercised in full their option to purchase an additional 1,350,000 common shares from the Selling Shareholders, priced at $16.00 per share, less underwriting discounts and commissions.
  • Barclays, J.P. Morgan, and Goldman Sachs & Co. LLC are acting as Joint Lead Bookrunning Managers for the Offering.
  • A registration statement relating to the common shares was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on May 22, 2024.

Hudbay Completes Upsized Bought Deal Equity Offering

Retrieved on: 
星期五, 五月 24, 2024
Offering, RBC Capital Markets, News, Indian stock exchange, National Bank of Canada, Bank of America, Exercise, TD Securities, HBM, Sale, BMO Capital Markets, Bank, Form, Constância, ING Group, Barclays, Scotiabank, Canaccord Genuity, TSX, Acceleration, Security (finance)

TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that the Company has closed its previously announced public offering of common shares of the Company (the “Common Shares”).

Key Points: 
  • TORONTO, May 24, 2024 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that the Company has closed its previously announced public offering of common shares of the Company (the “Common Shares”).
  • The underwriters exercised the full over-allotment option to purchase an additional 15% of the Common Shares in connection with the Offering.
  • The Company issued, on a bought deal basis, 42,366,000 Common Shares, including 5,526,000 Common Shares pursuant to the exercise of the over-allotment option, at a price of US$9.50 per Common Share for aggregate gross proceeds of US$402,477,000 (the “Offering”).
  • Forward-looking information herein includes, but is not limited to, statements related to the use of proceeds of the Offering and Hudbay’s business, objectives, strategies, and intentions.

Solaris Resources Announces $35 Million Common Share Bought Deal Offering

Retrieved on: 
星期二, 五月 21, 2024
Offering, Toronto Stock Exchange, WIRE, National bank, RBC Capital Markets, News, SLS, Indian stock exchange, Sale, BMO Capital Markets, NOT, Prospectus, SLSR, TSX, Security (finance)

VANCOUVER, British Columbia, May 21, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce that it has entered into an agreement with National Bank Financial Markets, RBC Capital Markets, and BMO Capital Markets as bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 7,150,000 common shares of the Company (the “Common Shares”) at a price of $4.90 per Common Share (the “Offering Price”), for aggregate gross proceeds of approximately $35,035,000 million (the “Offering”).

Key Points: 
  • If the Over-Allotment Option is exercised in full, the Company will receive additional gross proceeds of $5,255,250, for aggregate gross proceeds from the Offering of $40,290,250.
  • Securities Act”) and in such other jurisdictions outside of Canada in accordance with applicable law.
  • The preliminary short form prospectus, and any applicable amendment to the documents will be accessible through SEDAR+.
  • On behalf of the Board of Solaris Resources Inc.

IAMGOLD Announces US$300 Million Bought Deal Financing

Retrieved on: 
星期二, 五月 21, 2024
National bank, RBC Capital Markets, News, BMO Capital Markets, Form, Mineral, Attention, Gold, Legislation, Sale, Communication, Toronto Stock Exchange, Iamgold, Vesey Street, Syndicate, Environment, Offering, Bank statement, IAMGOLD, Register, Security (finance)

TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- IAMGOLD Corporation (“IAMGOLD” or the “Company”) today announced that it has entered into an agreement with a syndicate of underwriters led by National Bank Financial Markets, BMO Capital Markets and RBC Capital Markets pursuant to which they have agreed to purchase, on a bought deal basis, 72,000,000 common shares of the Company at a price of US$4.17 per common share (the “Offering Price”), for aggregate gross proceeds to the Company of approximately US$300 million (the “Offering”). The underwriters will also have the option, exercisable in whole or in part, at any time up to 30 days following the closing of the Offering, to purchase up to an additional 10,800,000 common shares at the Offering Price to cover over-allotments, if any. In the event that the option is exercised in its entirety, the aggregate gross proceeds of the Offering to the Company will be approximately US$345 million.

Key Points: 
  • In the event that the option is exercised in its entirety, the aggregate gross proceeds of the Offering to the Company will be approximately US$345 million.
  • The Côté Gold Mine is being operated through a joint venture (the "Côté Gold UJV" or "UJV") between IAMGOLD, as the operator, and Sumitomo.
  • As at March 31, 2024, this financial liability was US $366.8 million.
  • You may get documents filed with the SEC for free on the SEC’s Electronic Data Gathering, Analysis and Retrieval system at www.sec.gov .

Fidelis Insurance Group Announces Pricing of Secondary Offering of its Common Shares

Retrieved on: 
星期四, 五月 23, 2024
Professional Services, Insurance, Finance, Offering, Barclays, J. P. Morgan, Goldman Sachs, ISI, Telephone, Sale, BMO Capital Markets, Citigroup, Prospectus, Attention, UBS, Keefe, Bruyette & Woods, Broadridge Financial Solutions, Security (finance)

Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or “FIHL”), a global specialty insurer, today announced the pricing of an underwritten secondary public offering (the “Offering”) of 9,000,000 common shares by certain of its shareholders (the “Selling Shareholders”) at a price to the public of $16.00 per common share.

Key Points: 
  • Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or “FIHL”), a global specialty insurer, today announced the pricing of an underwritten secondary public offering (the “Offering”) of 9,000,000 common shares by certain of its shareholders (the “Selling Shareholders”) at a price to the public of $16.00 per common share.
  • In connection with the Offering, the Selling Shareholders have also granted the underwriters a 30-day option to purchase up to an additional 1,350,000 common shares of FIHL.
  • Fidelis Insurance Group is not selling any common shares in the Offering and will not receive any of the proceeds from the sale of the common shares offered by the Selling Shareholders.
  • A registration statement relating to the common shares was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on May 22, 2024.

Fidelis Insurance Group Announces Secondary Offering of its Common Shares

Retrieved on: 
星期一, 五月 20, 2024
Professional Services, Insurance, Finance, Offering, Barclays, J. P. Morgan, Goldman Sachs, ISI, Telephone, Sale, BMO Capital Markets, Citigroup, Prospectus, Attention, UBS, Keefe, Bruyette & Woods, Broadridge Financial Solutions, Security (finance)

Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or “FIHL”), a global specialty insurer, announced the launch of an underwritten secondary public offering (the “Offering”) of 9,000,000 common shares by certain of its shareholders (the “Selling Shareholders”).

Key Points: 
  • Fidelis Insurance Holdings Limited (NYSE:FIHL) (“Fidelis Insurance Group” or “FIHL”), a global specialty insurer, announced the launch of an underwritten secondary public offering (the “Offering”) of 9,000,000 common shares by certain of its shareholders (the “Selling Shareholders”).
  • In connection with the Offering, the Selling Shareholders intend to grant the underwriters a 30-day option to purchase up to an additional 1,350,000 common shares of FIHL.
  • Fidelis Insurance Group is not selling any common shares in the Offering and will not receive any of the proceeds from the sale of the common shares offered by the Selling Shareholders.
  • The common shares may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.